Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06953349 · ClinicalTrials.gov registry record
Efficacy of Surgical Systems in Combination With Phacoemulsification: a Retrospective Analysis
A clinical trial of Open Angle Glaucoma, sponsored by Barnet Dulaney Perkins Eye Centers.
- Recruiting
- Registry status
- 300
- Enrollment target
- 1
- Study location
NCT06953349: Recruiting study of Open Angle Glaucoma, sponsored by Barnet Dulaney Perkins Eye Centers.
NCT06953349 is a study of Open Angle Glaucoma that is actively recruiting participants, run by Barnet Dulaney Perkins Eye Centers. The registered enrollment target is 300 participants, roughly in line with the 324-participant average among 28 other Open Angle Glaucoma trials with a reported enrollment target. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06953349, a study of Open Angle Glaucoma, is actively recruiting participants, sponsored by Barnet Dulaney Perkins Eye Centers.
- RECRUITING
- Registry status
- 300 participants
- Enrollment target
- 1
- Study location
Study Summary
Real-World efficacy of Hydrus Microstent with OMNI Surgical System in combination with Phacoemulsification: a retrospective analysis
Primary Outcome
Primary endpoint stratified by complete or qualified success: • Proportion of patients with complete success (%) - without the use of medications
Conditions Studied
Interventions
- PROCEDURE Real-World efficacy of Hydrus Microstent with OMNI Surgical System in combination with Phacoemulsification: a retrospective analysis
Study Locations (1)
Arizona
- Barnet Dulaney Perkins Eye Center - Mesa
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 300 participants |
| Start Date | 2025-03-31 |
| Est. Completion | 2025-12-31 |
What NCT06953349 shows while recruiting
NCT06953349 is an observational study that tracks outcomes without assigning an intervention. The registered 300 participants enrollment target is mid-sized for trials with a published cap, roughly in line with the 324-participant average among 28 other Open Angle Glaucoma trials with a reported enrollment target.
The record links to 1 condition, with Open Angle Glaucoma appearing as the primary indexed condition, and to 1 intervention - of which Real-World efficacy of Hydrus Microstent with OMNI Surgical System in combination with Phacoemulsification: a retrospective analysis is the first listed.
NCT06953349 reports a single indexed study location in Arizona.
Frequently Asked Questions
What is clinical trial NCT06953349 about?
NCT06953349 is a clinical study titled "Efficacy of Surgical Systems in Combination With Phacoemulsification: a Retrospective Analysis". Real-World efficacy of Hydrus Microstent with OMNI Surgical System in combination with Phacoemulsification: a retrospective analysis
What is the current status of trial NCT06953349?
This trial is currently recruiting. The enrollment target is 300 participants. The study started on 2025-03-31. Estimated completion is 2025-12-31.
What conditions does trial NCT06953349 study?
This clinical trial studies the following conditions: Open Angle Glaucoma.
What interventions are being tested in trial NCT06953349?
The interventions under investigation include: Real-World efficacy of Hydrus Microstent with OMNI Surgical System in combination with Phacoemulsification: a retrospective analysis (PROCEDURE).
Who is sponsoring clinical trial NCT06953349?
This trial is sponsored by Barnet Dulaney Perkins Eye Centers, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06953349 being conducted?
This trial has 1 study location across Arizona. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Open Angle Glaucoma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06953349's enrollment target sits among peer trials
300 10th of 28 higher than 19 of 28 other Open Angle Glaucoma trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Open Angle Glaucoma trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
24-hour Effect of Rocklatan Compared With Latanoprost in Open Angle Glaucoma and Ocular Hypertension Patients
RECRUITING · Phase 4
-
Safety and Effectiveness of Minimally Invasive Micro Sclerostomy (MIMS®) to Reduce Intraocular Pressure in Open-Angle Glaucoma Which is Not Controlled Despite Polypharmacy
RECRUITING · NA
-
Efficacy of Simbrinza and Rocklatan vs Cosopt and Latanoprost
RECRUITING · Phase 4
-
Standalone iStent Infinite and iDose TR for Management of Moderate to Severe Open Angle Glaucoma
RECRUITING · Phase 4
-
A Randomized, Double-blind, Parallel-group, Two-arm, Multiple Dose, Multicenter, Bioequivalence Study With Clinical Endpoint in the Treatment of Subjects With Chronic Open-angle Glaucoma or Ocular Hypertension in Both Eyes
RECRUITING · Phase 1
-
AGN-193408 SR in the Treatment of Open-angle Glaucoma or Ocular Hypertension
RECRUITING · Phase 1
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00353483 · 300 participants
Effect of Neoadjuvant or Adjuvant Systemic Therapy on Breast Cancers, Bone Marrow Cancer Cells, and Circulating Cancer Cells
- NCT00588185 · 300 participants · NA
[18F]-Fluoro-2-Deoxy-D-Glucose and -[18F] Dihydro-Testosterone Pet Imaging in Patients With Progressive Prostate Cancer
- NCT00682032 · 300 participants · NA
The Effect of Beta-glucan in Non-Small Cell Lung Cancer
- NCT00870064 · 300 participants · NA
The Treatment of Type I Open Fractures in Pediatrics
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI